Nanoparticle-supported, rapid, digital quantification of neutralizing antibodies against SARS-CoV-2 variants
- 7 May 2025
- journal article
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 285, 117549
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- U.S. Department of Agriculture (AFRI 2022-67021-37013)
- National Institutes of Health (R21AI186134, DP2GM149552, R21AI169098, R01 AI157155)
- National Science Foundation (1847324)
This publication has 59 references indexed in Scilit:
- Metasurface‐Driven and Nanomaterial‐Coupled Plasmonic Biosensor for the Rapid and Quantitative Clinical Identification of Neutralizing Antibodies against SARS‐CoV‐2 VariantsAdvanced Functional Materials, 2023
- Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2Cell Host & Microbe, 2022
- Ultrabright nanoparticle-labeled lateral flow immunoassay for detection of anti-SARS-CoV-2 neutralizing antibodies in human serumBiomaterials, 2022
- An updated review of SARS‐CoV‐2 detection methods in the context of a novel coronavirus pandemicBioengineering & Translational Medicine, 2022
- Facile and Rapid Detection of Microalbuminuria by Antibody-Functionalized Gold NanorodsPlasmonics, 2022
- Synthetic nanobody-functionalized nanoparticles for accelerated development of rapid, accessible detection of viral antigensBiosensors and Bioelectronics, 2022
- A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variantsImmunity, 2021
- SARS‐CoV‐2 S1 is superior to the RBD as a COVID‐19 subunit vaccine antigenJournal of Medical Virology, 2020
- Cooperative binding by mouse IgG3 antibodies: implications for functional affinity, effector function, and isotype restrictionSpringer Seminars in Immunopathology, 1993
- Antibody affinity—III the role of multivalenceImmunochemistry, 1972